IBDEI1CI ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,23831,0)
 ;;=300.7^^127^1437^2
 ;;^UTILITY(U,$J,358.3,23831,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23831,1,2,0)
 ;;=2^300.7
 ;;^UTILITY(U,$J,358.3,23831,1,5,0)
 ;;=5^Hyponchondriasis
 ;;^UTILITY(U,$J,358.3,23831,2)
 ;;=^60556
 ;;^UTILITY(U,$J,358.3,23832,0)
 ;;=300.81^^127^1437^3
 ;;^UTILITY(U,$J,358.3,23832,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23832,1,2,0)
 ;;=2^300.81
 ;;^UTILITY(U,$J,358.3,23832,1,5,0)
 ;;=5^Somatization Disorder
 ;;^UTILITY(U,$J,358.3,23832,2)
 ;;=^112280
 ;;^UTILITY(U,$J,358.3,23833,0)
 ;;=307.1^^127^1438^1
 ;;^UTILITY(U,$J,358.3,23833,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23833,1,2,0)
 ;;=2^307.1
 ;;^UTILITY(U,$J,358.3,23833,1,5,0)
 ;;=5^Anorexia Nervosa
 ;;^UTILITY(U,$J,358.3,23833,2)
 ;;=^7942
 ;;^UTILITY(U,$J,358.3,23834,0)
 ;;=307.51^^127^1438^2
 ;;^UTILITY(U,$J,358.3,23834,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23834,1,2,0)
 ;;=2^307.51
 ;;^UTILITY(U,$J,358.3,23834,1,5,0)
 ;;=5^Bulemia Nervosa
 ;;^UTILITY(U,$J,358.3,23834,2)
 ;;=^17407
 ;;^UTILITY(U,$J,358.3,23835,0)
 ;;=307.50^^127^1438^3
 ;;^UTILITY(U,$J,358.3,23835,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23835,1,2,0)
 ;;=2^307.50
 ;;^UTILITY(U,$J,358.3,23835,1,5,0)
 ;;=5^Eating Disorder, NOS
 ;;^UTILITY(U,$J,358.3,23835,2)
 ;;=^37864
 ;;^UTILITY(U,$J,358.3,23836,0)
 ;;=333.99^^127^1439^2
 ;;^UTILITY(U,$J,358.3,23836,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23836,1,2,0)
 ;;=2^333.99
 ;;^UTILITY(U,$J,358.3,23836,1,5,0)
 ;;=5^Acute Akathisia
 ;;^UTILITY(U,$J,358.3,23836,2)
 ;;=^303698
 ;;^UTILITY(U,$J,358.3,23837,0)
 ;;=332.0^^127^1439^3
 ;;^UTILITY(U,$J,358.3,23837,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23837,1,2,0)
 ;;=2^332.0
 ;;^UTILITY(U,$J,358.3,23837,1,5,0)
 ;;=5^Parkinsonism
 ;;^UTILITY(U,$J,358.3,23837,2)
 ;;=^304847
 ;;^UTILITY(U,$J,358.3,23838,0)
 ;;=333.79^^127^1439^1
 ;;^UTILITY(U,$J,358.3,23838,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23838,1,2,0)
 ;;=2^333.79
 ;;^UTILITY(U,$J,358.3,23838,1,5,0)
 ;;=5^Acquired Torsion Dystonia NEC
 ;;^UTILITY(U,$J,358.3,23838,2)
 ;;=^334068
 ;;^UTILITY(U,$J,358.3,23839,0)
 ;;=333.85^^127^1439^4
 ;;^UTILITY(U,$J,358.3,23839,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23839,1,2,0)
 ;;=2^333.85
 ;;^UTILITY(U,$J,358.3,23839,1,5,0)
 ;;=5^Tardive Dyskinesia
 ;;^UTILITY(U,$J,358.3,23839,2)
 ;;=^334069
 ;;^UTILITY(U,$J,358.3,23840,0)
 ;;=V87.39^^127^1440^1
 ;;^UTILITY(U,$J,358.3,23840,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23840,1,2,0)
 ;;=2^V87.39
 ;;^UTILITY(U,$J,358.3,23840,1,5,0)
 ;;=5^Cont/Exp Hazard Sub NEC
 ;;^UTILITY(U,$J,358.3,23840,2)
 ;;=^336815
 ;;^UTILITY(U,$J,358.3,23841,0)
 ;;=310.0^^127^1441^1
 ;;^UTILITY(U,$J,358.3,23841,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23841,1,2,0)
 ;;=2^310.0
 ;;^UTILITY(U,$J,358.3,23841,1,5,0)
 ;;=5^Frontal Lobe Syndrome
 ;;^UTILITY(U,$J,358.3,23841,2)
 ;;=^265201
 ;;^UTILITY(U,$J,358.3,23842,0)
 ;;=310.1^^127^1441^3
 ;;^UTILITY(U,$J,358.3,23842,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23842,1,2,0)
 ;;=2^310.1
 ;;^UTILITY(U,$J,358.3,23842,1,5,0)
 ;;=5^Personality Chg d/t TBI/Lesion
 ;;^UTILITY(U,$J,358.3,23842,2)
 ;;=^331953
 ;;^UTILITY(U,$J,358.3,23843,0)
 ;;=310.2^^127^1441^4
 ;;^UTILITY(U,$J,358.3,23843,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23843,1,2,0)
 ;;=2^310.2
 ;;^UTILITY(U,$J,358.3,23843,1,5,0)
 ;;=5^Postconcussion Syndrome
 ;;^UTILITY(U,$J,358.3,23843,2)
 ;;=^265160
 ;;^UTILITY(U,$J,358.3,23844,0)
 ;;=310.81^^127^1441^5
 ;;^UTILITY(U,$J,358.3,23844,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23844,1,2,0)
 ;;=2^310.81
 ;;^UTILITY(U,$J,358.3,23844,1,5,0)
 ;;=5^Pseudobulbar Affect
 ;;
 ;;$END ROU IBDEI1CI
